Affimed Story

<div class='circular--portrait' style='background:#006400;color: #F5FFFA;font-size:4em;'>AN</div>
AFMD -- USA Stock  

USD 9.62  0.11  1.16%

While some of us are excited about healthcare space, it makes sense to digest Affimed NV in greater detail to make a better perception of its potential. As we have suggested previously, Affimed NV is beginning its dip as shareholders shift to be more bearish due to the increased sector volatility. Affimed NV almost mirrors the market. The company returns are highly-related to returns on the market. As market moves, the company is expected to follow. Sound primary indicators of the firm may indicate signs of shorter-term price drift for shareholders. Affimed NV is scheduled to announce its earnings today. The upcoming quarterly report is expected on the 27th of April 2021.
Published over a week ago
View all stories for Affimed NV | View All Stories
Our latest technical analysis of Affimed NV (NASDAQ:AFMD)
This firm's average rating is Strong Buy from 3 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Affimed NV market sentiment investors' perception of the future value of Affimed. Let us look at a few aspects of Affimed technical analysis. About 60.0% of the company shares are held by institutions such as insurance companies. Affimed NV recorded a loss per share of 0.61. The entity had not issued any dividends in recent years.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Affimed NV. In general, we focus on analyzing Affimed NV stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Affimed NV's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Affimed NV's intrinsic value. In addition to deriving basic predictive indicators for Affimed NV, we also check how macroeconomic factors affect Affimed NV price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Affimed NV's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Affimed NV in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Affimed NV. Your research has to be compared to or analyzed against Affimed NV's peers to derive any actionable benefits. When done correctly, Affimed NV's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Affimed NV.

How does Affimed Stands against Peers?

Analyzing Affimed NV competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Affimed NV across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Affimed NV Competition Details

How Affimed utilizes its cash?

To perform a cash flow analysis of Affimed NV, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Affimed NV is receiving and how much cash it distributes out in a given period. The Affimed NV cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Affimed NV Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (19.61 Million)

Closer look at Affimed NV Semi Deviation

Affimed NV has current Semi Deviation of 3.7. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
=  
SQRT(SV) 
 = 
3.7
SQRT = Square root notation
SV =   Affimed NV semi variance of returns over selected period
Let's now compare Affimed NV Semi Deviation to its closest peers:
AFMD
DMAC
EQ
DVAX
EARS
AFMD3.7039771466929223
DMAC4.06
EQ5.0
DVAX4.17
EARS6.31

Time to quit on of Affimed NV?

Latest Sortino Ratio is up to 0.09. Price may dip again.
As of the 6th of April, Affimed NV shows the mean deviation of 3.75, and Risk Adjusted Performance of 0.0877. Affimed NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for Affimed NV, which can be compared to its rivals. Please confirm Affimed NV downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Affimed NV is priced correctly, providing market reflects its regular price of 7.78 per share. Given that Affimed NV has jensen alpha of 0.3663, we suggest you to validate Affimed NV's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Take On Affimed NV

Although few other entities in the biotechnology industry are either recovering or due for a correction, Affimed may not be as strong as the others in terms of longer-term growth potentials. On the whole, as of the 6th of April 2021, our actual 30 days recommendation on the firm is Hold. We believe Affimed NV is undervalued with below average odds of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Affimed NV. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com